COVID-19 Renews Quest for Coronavirus Vaccine

By Carol Pearson | VOA News |

Pharmacist Michael Witte opens a frozen package of the potential vaccine for COVID-19 on the first day of a first-stage safety study clinical trial, at the Kaiser Permanente Washington Health Research Institute in Seattle. Washington, March 16, 2020.

WASHINGTON – The world crossed the one-million mark of confirmed COVID-19 cases this past week. With untold millions more possible in the months to come, scientists are committed to making a vaccine.

There’s a lot about COVID-19 that scientists still don’t know. They don’t know entirely how it is spread. And without proven treatments or vaccines, good hygiene and staying away from other people are the only known methods of prevention.

Dr. Peter Hotez at Baylor College of Medicine started working on a coronavirus vaccine in 2003, during the outbreak of SARS, but after that, research funds dried up.

Hotez expects more coronaviruses to develop and spread. Some may be more benign that COVID-19, some far deadlier.

“Pandemics for coronaviruses have become a new normal. That we saw with SARS in 2003. We saw it in MERS s in 2012, and now this one. So we can expect a new major coronavirus every decade.

Read more of this report

(Visited 108 times, 1 visits today)
About Cholo Brooks 14008 Articles
Joel Cholo Brooks is a Liberian journalist who previously worked for several international news outlets including the BBC African Service. He is the CEO of the Global News Network which publishes two local weeklies, The Star and The GNN-Liberia Newspapers. He is a member of the Press Union Of Liberia (PUL) since 1986, and several other international organizations of journalists, and is currently contributing to the South Africa Broadcasting Corporation as Liberia Correspondent.